Ultralife Corporation (ULBI): PESTLE Analysis [Nov-2025 Updated]

If you hold Ultralife Corporation (ULBI), you know its trajectory hinges on more than just internal execution; it's a direct play on defense policy and battery science. Right now, the stability of U.S. defense contracts provides a solid revenue floor, anchored near the Q3 2024 figure of approximately $30.0 million, but that stability is constantly challenged by two major forces: the inflationary squeeze on critical materials like lithium and the rapid technological shift toward higher energy density chemistries. You need to understand how geopolitical tensions create demand, but also how strict International Traffic in Arms Regulations (ITAR) compliance and the looming threat of solid-state competitors could defintely complicate the next two years. Let's dive into the six macro-factors that will truly drive ULBI's stock price.

Ultralife Corporation (ULBI) - PESTLE Analysis: Political factors

The political landscape is a clear tailwind for Ultralife Corporation's (ULBI) core business, but it brings a specific set of compliance and revenue risks you need to map. The key takeaway is that massive, sustained U.S. and NATO defense spending is driving strong demand, yet regulatory friction like tariffs and the inherent lumpiness of government contracts create volatility.

U.S. defense budget stability drives demand for military batteries.

The sheer scale of U.S. defense spending creates a stable, high-value market for Ultralife's power solutions. The Fiscal Year (FY) 2025 National Defense Authorization Act (NDAA) sets a cap of approximately $895 billion for national defense funding, ensuring a robust budget for modernization and procurement. This stability is critical, as military batteries are consumables that require constant replenishment, especially with the increased deployment of battery-dependent technologies like unmanned aerial systems (drones).

Ultralife is capitalizing on this trend, reporting that its Government Defense sales for the Battery & Energy Products segment increased by 19.0% in the third quarter of 2025 and a massive 61.1% in the second quarter of 2025. This growth reflects strong demand from a U.S.-based global prime contractor. The Pentagon's focus on supply chain resilience is also a direct opportunity, with the FY 2025 budget allocating significant funds to domestic mineral and supply chain development:

• $1 billion for Defense Production Act appropriations to bolster mineral production
• $2 billion to upgrade critical mineral stockpiles
• $5 billion for investments in critical minerals supply chains

This is a defintely bullish signal for domestic suppliers like Ultralife.

International Traffic in Arms Regulations (ITAR) compliance is a constant operational cost.

Selling military-grade products requires strict adherence to the International Traffic in Arms Regulations (ITAR) and Export Administration Regulations (EAR), which govern the export of defense-related articles. This compliance is a non-negotiable operational cost and a source of friction. While the company's SEC filings indicate that ITAR/EAR compliance costs are not currently considered significant relative to total sales volume, the broader political environment introduces other regulatory costs, specifically tariffs.

In the first half of 2025, the company's consolidated gross margin saw a decline of up to 300 basis points, partly attributable to the impact of tariffs. To mitigate this, Ultralife implemented a direct political-cost pass-through mechanism for customers:

Regulatory Cost Factor (FY 2025)	Impact on Operations	Quantifiable Cost/Action
ITAR/EAR Compliance	Mandatory for all defense exports; risk of penalties for non-compliance.	Ongoing administrative and legal overhead (not separately quantified as material cost).
Tariffs (Trade Policy)	Increased cost of imported components, impacting gross margin.	Applied a tariff-related surcharge of 3.5% on affected SKUs, effective May 15, 2025.

This tariff surcharge, applied to open and future orders, is a clear example of how geopolitical trade policies translate directly into higher costs for the end-user, but it also protects Ultralife's gross margin, which was 22.2% in Q3 2025.

Geopolitical tensions increase urgency for reliable power solutions from NATO allies.

Global instability, particularly the war in Ukraine and rising tensions with Russia, has spurred a significant defense spending surge among NATO allies. This directly translates to increased demand for Ultralife's military power and communications products. NATO leaders are pushing for a new defense spending benchmark, with some proposals suggesting a combined 5% of GDP, up from the long-standing 2% target.

Ultralife is strategically positioned to capture this international demand, which is supported by its acquisition of UK-based Accutronics. This move provides a European base for shipping and sales, allowing the company to better serve NATO members who are increasing their military budgets. The company's international sales, while currently a smaller portion of the Battery & Energy Products segment (domestic to international split was 72%-28% in Q3 2025), are poised for growth as European governments focus on Urgent Operational Requirements (UORs) for reliable, off-the-shelf components.

Government contract renewal cycles create revenue lumpiness and risk.

The nature of government procurement, which relies on large, multi-year contracts and defined renewal cycles, introduces inherent revenue lumpiness. Ultralife's strong backlog of $90.1 million as of the end of Q3 2025 provides stability, with 45% of that backlog coming from government defense customers.

However, the risk is evident in the Communications Systems segment, which is heavily reliant on government contracts. This segment's sales declined by 36.2% in Q1 2025 and a sharp 57.2% in Q2 2025, primarily due to the 'timing of expected larger orders.' This is a textbook example of contract lumpiness. A prolonged delay, or a formal protest from an unsuccessful bidder, can materially affect short-term financials. The company must manage this risk by diversifying its contract portfolio and ensuring continuous new product development to secure follow-on awards, like the next-generation amplifier pre-production units expected in Q1 2026.

Ultralife Corporation (ULBI) - PESTLE Analysis: Economic factors

Inflationary pressure on key raw materials like lithium and cobalt squeezes margins.

You're seeing a classic margin squeeze in the battery business, and Ultralife Corporation is defintely not immune. While the dramatic peak in raw material costs from 2022 to 2023 has cooled-lithium carbonate prices dropped over 80% from their high-the market remains volatile. For a company like Ultralife, which relies on these materials for its Battery & Energy Products segment, the risk isn't just price spikes; it's the volatility that makes long-term contracting a nightmare.

The gross margin for Ultralife tells the story: it fell to 22.2% in Q3 2025, down from 24.3% in Q3 2024. This 210-basis point drop is partly attributed to manufacturing inefficiencies and a lower gross margin in the Battery & Energy Products segment. Honestly, even with an oversupply putting pressure on cobalt prices, the risk of a supply shock or a sudden restocking phase in the lithium market-where prices stabilized around $11/kg-could quickly reverse the cost trend and hit profits hard.

• Gross Margin (Q3 2025): Fell to 22.2%.
• Lithium Price: Stabilized around $11/kg, still 50% above 2020 lows.
• Cobalt Market: Oversupply pressure, but geopolitical risk remains high.

Strong U.S. dollar makes international sales less competitive on price.

The strengthening U.S. dollar is a double-edged sword for any American exporter. While a strong dollar can make imported components cheaper for Ultralife, it makes their finished products-like military batteries and communication systems-more expensive for international customers buying in local currency. This is a direct headwind to sales volume.

To be fair, the company reported a foreign currency gain in its Q3 2025 results, which is a positive from a balance sheet perspective, but it also reflects the underlying strength of the dollar that pressures the top line. Non-U.S. revenue accounted for $11.4 million, or 26% of the total Q3 2025 sales. That's a quarter of your business facing a price disadvantage simply due to currency translation. You have to be aggressive with pricing and value-add to overcome that structural headwind.

Near-term revenue is anchored by Q3 2025 figures of approximately $43.4 million.

The near-term revenue picture is anchored by the most recent quarterly performance. Ultralife reported Q3 2025 sales of $43.4 million, a solid 21.5% increase from the $35.7 million reported in Q3 2024. This growth is largely driven by the Battery & Energy Products segment, which saw sales of $39.9 million, including the contribution from the Electrochem acquisition.

More importantly, the total backlog exiting Q3 2025 stood at a healthy $90.1 million, up from $84.5 million exiting Q2 2025. This backlog gives you visibility into the next several quarters, which is gold in this business. The strong demand from government/defense customers is the primary engine here, with government/defense sales increasing 19.0% in the Battery & Energy Products segment, excluding the acquisition impact. That's a good anchor.

Metric	Q3 2025 Value	Q3 2024 Value	Year-over-Year Change
Total Revenue	$43.4 million	$35.7 million	+21.5%
Battery & Energy Products Sales	$39.9 million	$32.5 million	+22.8%
Backlog (Exiting Quarter)	$90.1 million	$78.0 million	+15.5%

Interest rate environment affects capital expenditure for facility and equipment upgrades.

The higher-for-longer interest rate environment is a clear headwind for capital investment, especially when you are integrating an acquisition. Ultralife's interest expense for Q3 2025 was a significant $992K, which is a huge jump from the $173K reported in the prior-year quarter. This spike is directly tied to the financing of the Electrochem acquisition completed in late 2024.

The company now carries a long-term debt outstanding of $50.9 million as of Q3 2025. While management is focused on 'strategic capital investments' and has freed up cash by reducing inventory, the increased cost of debt means every dollar spent on facility and equipment upgrades now comes with a higher hurdle rate. This makes every CapEx decision much tougher. The good news is they are still making those strategic investments to capture manufacturing cost efficiencies.

Ultralife Corporation (ULBI) - PESTLE Analysis: Social factors

Growing societal focus on supply chain transparency and ethical sourcing of minerals.

The market is defintely demanding that companies show where their raw materials come from, especially for critical battery components like the 3TG minerals (tin, tantalum, tungsten, and gold). This isn't just a compliance issue anymore; it's a reputational one. A lack of supply chain transparency (the ability to track a product from its origin to the customer) now creates significant operational and legal risks.

For Ultralife Corporation, this means continuous, formal due diligence. The company filed its Form SD in May 2025, confirming its commitment to responsible sourcing. They actively work with suppliers to identify the source of smelters and refiners (SORs) and use the standardized Responsible Minerals Initiative (RMI) Conflict Minerals Reporting Template (CMRT) to gather sourcing information. This systematic approach is the only way to mitigate the risk of indirectly financing armed groups in Covered Countries, which is a core concern for investors and government clients alike.

Demand for portable, reliable power in remote medical and emergency services.

The need for reliable, portable power in critical applications-like remote medical monitoring and first responder equipment-is surging. The global market for Portable Medical Power Supply Devices is projected to reach an estimated $1.25 billion by 2025, showing a robust Compound Annual Growth Rate (CAGR) of 7.2% through 2033. Also, the market for Portable Power Stations for First Responders, which was valued at $1.21 billion in 2024, is expected to grow at a CAGR of 9.7% from 2025 to 2033. This is a massive tailwind for Ultralife's Battery & Energy Products segment.

Still, you have to watch the execution. While Ultralife Corporation serves the Medical market, the company reported headwinds in the first half of 2025. Specifically, Q2 2025 commercial sales were impacted by a 39% decrease in medical battery sales, which management attributed to order timing. This highlights how sensitive even high-demand sectors are to customer-specific purchasing cycles. The overall Battery & Energy Products segment remains strong, but the medical sub-segment needs consistent order flow to capture the full market opportunity.

Workforce skills gap in specialized battery engineering and manufacturing.

The US battery industry is facing a significant talent shortage, and this is a tangible risk to production capacity. The Center for Automotive Research (CAR) found that 82% of industry respondents reported a shortage of skilled local applicants. The skills gap is particularly acute in specialized areas that are core to Ultralife's business, such as electrochemistry, battery chemistry, battery management systems, and specialized manufacturing.

Here's the quick math: the broader engineering sector, which includes defense and healthcare, is projected to need over 30,000 new engineers by 2029. Ultralife Corporation relies on global applications engineering teams for its mission-critical solutions, so competition for this talent is fierce. The cost of recruiting and retaining a specialized electrochemist in 2025 is substantially higher than in previous years, which pressures operating expenses. You can't just hire a general engineer; you need a battery specialist. That's the challenge.

Increased public scrutiny on defense contractor ethics and performance.

As a key supplier to the US government and defense agencies, Ultralife Corporation operates under intense public and regulatory scrutiny. The company's reliance on this sector is significant, with the commercial-to-government/defense sales split for Q2 2025 at 65/35. Furthermore, the Battery & Energy Products segment saw a 19.0% rise in government/defense sales in Q3 2025.

This reliance is a double-edged sword. On one hand, it drives revenue, as evidenced by the $5.2 million award received from the U.S. Defense Logistics Agency (DLA) in September 2025 for its BA-5390 military batteries. On the other hand, any perceived ethical lapse, performance failure, or delay in a defense contract can lead to immediate public backlash, which can quickly translate into contract losses or tighter regulatory oversight. The company itself notes that 'reductions in revenues from key customers' and 'delays or reductions in US and foreign military spending' are material risks. The social factor here is the public's low tolerance for defense contractor missteps, which directly impacts the stability of a core revenue stream.

ULBI Social Factor - 2025 Data Snapshot	Key Metric/Value	Source/Impact
Supply Chain Transparency Action	Form SD filed May 2025	Formal due diligence on 3TG minerals using RMI CMRT.
Medical Battery Sales Trend (Q2 2025)	-39% decrease (YoY)	Decline in commercial medical battery sales due to order timing.
Portable Medical Market Size (2025 Est.)	$1.25 billion	Strong industry tailwind for Ultralife's Battery & Energy Products.
Government/Defense Sales Growth (Q3 2025)	+19.0% increase	Growth in the Battery & Energy Products segment from government/defense.
Defense Contract Award (Sept 2025)	$5.2 million from DLA	Concrete evidence of continued reliance on the defense sector.
Industry Skills Gap (US Battery)	82% of companies report skilled applicant shortage	Direct hiring challenge for specialized battery engineers and technicians.

• Monitor supplier compliance with RMI standards quarterly.
• Develop a retention plan for electrochemistry engineers.
• Track medical order timing to smooth revenue volatility.
• Maintain impeccable performance on DLA contracts.

Ultralife Corporation (ULBI) - PESTLE Analysis: Technological factors

Rapid shift toward higher energy density lithium-ion chemistries requires R&D investment.

You're seeing the battery market move fast, and Ultralife Corporation is defintely feeling the pressure to keep pace with higher energy density lithium-ion (Li-ion) chemistries. This isn't just about making a battery last longer; it's about packing more power into the same or smaller military-standard form factor. So, the company is spending more to stay relevant.

In the first half of the 2025 fiscal year, Ultralife Corporation significantly ramped up its investment in new product development. Specifically, the company reported a 24% increase in new product development costs in Q1 2025 and a 25.3% increase in Q2 2025 compared to the prior year periods. This investment is translating into tangible products, like the enhanced version of their popular UBI-2590 rechargeable battery, which is now modified to safely deliver up to 15 or even 30 amps, a substantial jump from the standard 10 amps. That's a critical difference in the field when you need to power advanced sensors or high-draw radios.

Competitors are advancing solid-state battery technology, posing a long-term threat.

The real long-term threat isn't just better Li-ion; it's the next generation: solid-state batteries (SSBs). While SSBs replace the liquid electrolyte in traditional Li-ion with a solid material, offering higher energy density and enhanced safety by reducing fire risk, they're still mostly in the development and early adoption phase right now.

The commercial market is pushing this hard, with companies like Solid Power and Factorial Energy validating large-format cells in 2025. Industry analysts project commercial-scale application in electric vehicles (EVs) from as early as 2027. Since Ultralife Corporation's core value proposition rests on safety and energy density for defense and industrial applications, this development is a clear, future risk. The company needs to be watching this space closely, because a commercially viable, military-grade SSB could quickly disrupt their rechargeable battery business.

Battery Technology Trend (2025)	Impact on Ultralife Corporation	Commercialization Timeline
Higher Energy Density Li-ion	Requires continuous R&D spending; leads to new products like the UBI-2590 variant delivering up to 30 amps.	Immediate/Near-Term (2025)
Solid-State Batteries (SSBs)	Long-term competitive threat due to superior safety and energy density; currently in advanced R&D by competitors like Solid Power.	Market Entry Projected: 2027-2030 for mass-market EVs

ULBI's focus on non-rechargeable military batteries provides a niche stability.

To be fair, Ultralife Corporation has a strong, stable niche that insulates it from some of the rechargeable battery market volatility: non-rechargeable lithium manganese dioxide batteries. This is where reliability and long shelf life trump recharge cycles, especially for stockpiling and remote deployment.

This focus continues to pay off in 2025. In September 2025, the company secured an award valued at approximately $5.2 million from the U.S. Defense Logistics Agency (DLA) for its legacy BA-5390 military batteries. This is a clear indicator of sustained demand for their established, non-rechargeable technology. The company's government/defense sales (excluding the Electrochem acquisition) increased by 19.0% in the Battery & Energy Products segment in Q3 2025, which underpins the strategic stability of this niche.

Need to integrate power systems with evolving military communication gear.

The modern battlefield is a network, and every soldier is a node. This means Ultralife Corporation isn't just selling batteries; they're selling integrated power and communications solutions. The demand is shifting from simple power sources to complex power management systems that work seamlessly with new military communication gear.

The company's Communications Systems segment is directly addressing this with new products:

• Launched the A-2303, a compact, energy-efficient military amplifier designed for easy integration with existing personal role radios (PRRs).
• Showcasing a new conformal wearable battery that is lightweight and bends around the body for a comfortable fit.
• Developing a body-worn, battery-powered edge computer server, the Crescent server, for local data processing in the field.

The challenge is that this segment is prone to order timing delays. For example, the Communications Systems segment's sales for Q2 2025 were only $2.7 million, a 57.2% decline from the prior year, primarily due to delayed purchase orders. This volatility highlights that while the technology is critical, the sales cycle for complex integrated systems is long and unpredictable.

Ultralife Corporation (ULBI) - PESTLE Analysis: Legal factors

As a seasoned analyst, I know that legal factors aren't just about avoiding fines; they're about managing operational risk that directly impacts your cost structure and market access. For Ultralife Corporation, a company heavily invested in defense and specialized power solutions, compliance is a core competency, not an afterthought. The key legal pressures in 2025 revolve around transport safety, stringent government contract oversight, intellectual property defense, and evolving environmental mandates for battery end-of-life.

Compliance with UN 38.3 regulations for the transport of lithium batteries is mandatory.

You simply cannot ship lithium batteries by air freight-a critical channel for time-sensitive defense and medical customers-without passing the UN 38.3 tests. This mandate, part of the United Nations' Recommendations on the Transport of Dangerous Goods, requires batteries to undergo eight rigorous tests, including altitude simulation, vibration, and thermal cycling, to ensure safety during transit. Ultralife Corporation must maintain current certification for every product line, and the failure rate for initial UN 38.3 testing across the industry is high, with some estimates suggesting up to 30% of projects fail the first time.

Here's the quick math: Certification costs are a recurring operational expense for new or modified battery models. The average test charge for a single lithium-ion battery pack model's UN 38.3 certification is approximately $1,300. This cost is minor compared to the risk of non-compliance, which can lead to costly delays and product seizures, a scenario the company explicitly lists as a risk.

Strict government procurement rules and contract auditing procedures.

Ultralife Corporation's significant reliance on government and defense contracts means it operates under a heightened level of legal and financial scrutiny. These contracts are subject to complex U.S. and foreign procurement laws that govern everything from pricing to quality control. Failure to comply can result in civil or criminal proceedings, including suspension of payments or debarment from future contracting.

The financial scale of this risk is clear in the 2025 results. For the first quarter of 2025, the company's Government/Defense Revenue was a substantial $21.087 million. Furthermore, Q3 2025 Government/Defense sales increased by 19.0%, reflecting strong demand. This growth is a huge opportunity, but it also increases exposure to government audits of the cost accounting and contract performance. A single, recent award from the U.S. Defense Logistics Agency (DLA) for its BA-5390 military batteries was valued at approximately $5.2 million in September 2025.

The company also faces ongoing compliance requirements like the 'conflict minerals' disclosure under the Dodd-Frank Act, which requires due diligence on the supply chain for minerals from the Democratic Republic of Congo and adjoining countries.

2025 Government/Defense Financial Metric	Value/Percentage	Legal Implication
Q1 2025 Government/Defense Revenue	$21.087 million	Scale of revenue subject to strict Federal Acquisition Regulations (FAR) and contract auditing.
Q3 2025 Government/Defense Sales Growth	19.0% increase	Increased volume and complexity of contracts requiring compliance oversight.
Q3 2025 Backlog Composition	45% from government defense customers	Future revenue stream heavily dependent on maintaining compliance and avoiding debarment risk.

Intellectual property (IP) protection is vital against Asian battery manufacturers.

The lithium battery market is a hotbed of intellectual property disputes, especially with high-volume Asian manufacturers. Protecting Ultralife Corporation's proprietary designs for its specialized military and industrial batteries is defintely critical for maintaining its competitive edge and premium pricing. The industry trend shows a rise in IP litigation as the value of the battery market continues to increase.

The risk is not just direct theft but the high cost of defense. Even without a major public case in 2025, the company must allocate resources to continuous patent monitoring and defense, particularly against large players like CATL, COSMX, and ATL, who are also actively defending their own IP. This is a cost of doing business in a high-tech, global industry.

Environmental Protection Agency (EPA) rules on battery waste disposal are tightening.

The regulatory landscape for lithium battery disposal is changing rapidly, driven by the sheer volume of end-of-life batteries. The EPA is actively pursuing a rulemaking effort in 2025 to modify and expand the Resource Conservation and Recovery Act (RCRA) Universal Waste Rule for lithium batteries.

The key legal development in 2025 is the expected proposal of a new, distinct category of universal waste specifically for lithium batteries, with a Notice of Proposed Rulemaking anticipated around June 2025. This proposal aims to:

• Establish a clear, practical system for handling discarded lithium batteries.
• Improve safety standards and reduce fire risks from mismanaged batteries.
• Promote the collection and recycling of critical minerals.

What this estimate hides is the potential for new, costly compliance requirements on manufacturers like Ultralife Corporation, particularly regarding take-back schemes, labeling, and disposal documentation. While the final rule is not expected until around August 2027, the industry is already preparing for a shift from the current, less-stringent universal waste rules to a more prescriptive framework. This means the company must start budgeting for increased waste management costs and potential investment in new recycling partnerships now.

Next Step: Legal and Compliance teams must draft a detailed impact assessment of the anticipated EPA Universal Waste Rule changes by the end of Q1 2026 to forecast compliance capital expenditures.

Ultralife Corporation (ULBI) - PESTLE Analysis: Environmental factors

Pressure to reduce the carbon footprint of manufacturing and logistics operations.

The global push for decarbonization directly impacts Ultralife Corporation, particularly in its manufacturing and complex logistics network. While the company does not publicly report a specific Scope 1 or 2 carbon footprint number for 2025, the pressure is real and shows up in operational costs.

For instance, the Q2 2025 financial results cited 'higher tariff and freight costs' as a factor contributing to the gross margin compression. This highlights the financial risk associated with a global supply chain that is not fully optimized for low-carbon transport. Reducing the carbon footprint means optimizing factory throughput and sourcing closer to the point of use, which is a significant undertaking.

Here's the quick math on the financial impact of supply chain efficiency:

Finance: Track raw material cost changes against that $30.0 million quarterly revenue base by the end of this quarter.

Dependency on mining and processing of critical battery minerals like nickel and cobalt.

Ultralife Corporation's diverse product portfolio, which includes Lithium-ion rechargeable packs and various non-rechargeable chemistries, means it faces varying levels of exposure to critical mineral volatility. The broader battery market is seeing a shift toward Lithium Iron Phosphate (LFP) technology, which is a major advantage because it sidesteps the need for costly and ethically complex cobalt and nickel.

Still, for high-energy density applications, nickel-cobalt-based chemistries remain necessary, keeping the supply chain risk alive. The global cobalt market is forecast to see an oversupply of approximately 21,000 metric tons in 2025, which should keep near-term price volatility subdued, but the long-term geopolitical risk remains defintely high.

The company's gross margin in Q3 2025 was already impacted, falling to 22.2%, partly due to 'manufacturing inefficiencies resulting from quality issues associated with some incoming raw materials.' This shows the direct financial consequence of reliance on a global, mineral-dependent supply chain.

Focus on developing more sustainable, recyclable battery chemistries.

The industry is rapidly evolving toward more sustainable battery chemistries, and Ultralife Corporation is involved through its various product lines. The shift to LFP and emerging Sodium-ion batteries is driving a trend that can reduce CO2 emissions by an estimated 30% in the production process alone.

The company's subsidiary, Southwest Electronic Energy, explicitly lists Recycling as one of its services, indicating an existing infrastructure or process for end-of-life management. While Ultralife Corporation offers a range of rechargeable and non-rechargeable cells, the strategic move is toward those with a clearer path to material recovery.

The market is seeing recycling methods, such as advanced hydrometallurgical processes, achieving recovery rates above 95% for key metals, setting a high bar for all battery manufacturers.

Increasing customer preference for ISO 14001-certified suppliers.

Customer demand, especially from large government and defense clients, increasingly favors suppliers with verified Environmental Management Systems (EMS). Ultralife Corporation is well-positioned here, as several of its key international operations hold the ISO 14001:2015 certification.

This certification is an internationally recognized standard that helps manage, monitor, and control environmental issues, guiding the company toward more efficient resource use and waste reduction. This is a critical competitive edge, particularly in Europe and Asia.

The following Ultralife Corporation facilities are ISO 14001-registered:

• ABLE (China)
• Accutronics (United Kingdom)

This certification helps mitigate the risk of losing major contracts to more environmentally compliant competitors.